HPV blood test to predict cervical cancer return after surgery
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies a blood test that looks for HPV DNA after cervical cancer surgery. The test may help doctors predict if the cancer might come back and decide if more treatment is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of cervical cancer called squamous cell carcinoma, HPV-associated adenocarcinoma, or adenosquamous carcinoma.
- Your cancer is at an early stage (IB1 to II) and you are having surgery to remove the cancer.
- You have a type of HPV that can be detected in your blood or tumor tissue.
- You are willing to have blood tests and follow-up visits as part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.
This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.
This trial uses a simple blood test to look for cancer DNA (ctDNA) and HPV DNA after cervical cancer surgery. The goal is to detect any return of the cancer early, so you and your doctor can act quickly.
This study checks whether a blood test for HPV16 DNA can predict when HPV-related throat cancer comes back after treatment. It may help improve follow-up care by catching recurrence earlier.
This study looks at whether HPV infection stays in the body during and after standard radiation treatment for cervical cancer, and if that affects how well the treatment works. It aims to understand more about why some people respond better than others.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.